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Using the IRB Harmonization and Reliance Document Can 
Reduce Review and Regulatory Delays for the Benefit of All
Stephen Sodeke
Tuskegee University National Center for Bioethics in Research and Health Care & College of 
Veterinary Medicine, Nursing, and Allied Heath
In “IRB and Research Regulatory Delays Within the Military Health Care Setting: Do They 
Really Matter? And If So, Why and for Whom?,” Freed and colleagues (Freed et al. 2016) 
proposed four areas of improvement in attempts to resolve the structural and attitudinal 
challenges in military health research. The improvements proposed include (1) 
standardization of the institutional review board (IRB) processes and forms across the 
Department of Defense (DoD), (2) priorities for federally funded studies, (3) transparency of 
processes and collection of metrics, and (4) order and necessity of science reviews. The 
structural and systemic challenges described are not unique to DoD; they are long-standing 
in the research enterprise. For instance, although Lind (1992) wrote about the evolution of 
the IRB as an ethics committee, Edgar and Rothman (1995) called attention to problems 
with the use of IRBs, and to challenges to the ethics of human experimentation that can be 
expected in the future. In 1998, Moreno (1998) and the Department of Health and Human 
Services called for a reform of IRBs. Wolf et al. (2002) explored the challenges of IRB 
review and human subject protections in practice-based research. For multicenter clinical 
trials, medical innovations often call for interdependence of partnering institutions and 
university–industry connections (Gelijns and Their 2002). Nevertheless, the ethically 
challenging multicenter protocols often required multiple IRB reviews that were inconsistent 
in outcomes, and, at times, confusing, as different IRBs can reach different conclusions. 
Corbie-Smith and colleagues (1999) highlighted the importance of involving appropriate 
stakeholders to bring perspectives from scientific, research ethics, and participant 
communities to bear on IRB attempts to address the ethical challenges that they face. 
Furthermore, Menikoff (2010) noted that no evidence exists showing that multiple reviews 
of a single study make it safer, better, or more ethical. The point by Freed and colleagues 
(2016) that multiple reviews provide “the appearance of added benefit and the diffusion of 
responsibility were adverse events to occur” is well taken. Nevertheless, Christian and 
colleagues (2002) proposed a central IRB for multi-institutional trials, and Silberman and 
Khan (2011), who explored the IRB-imposed burdens on research, called for regulatory 
reform. Sirotin and colleagues (2010), however, showed how IRB chairs found resources 
that could address problems rather than settling for expanded guidance from the Office of 
Human Research Protections.
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To make arguments for reform, Freed and colleagues (2016) used two compelling cases. The 
observations conveyed in these instances “hit close to home” in that I currently serve as the 
chair of the Ethics and Regulatory Sub-committee of the Research Centers for Minority 
Institutions (RCMI) Translational Research Network (RTRN), a partnership of 18 
institutions engaged in a cooperative network to reduce health disparities. I substantiate the 
authors’ proposal to resolve the quagmire they describe and share our experience that 
demonstrates how using IRB harmonization and reliance, when appropriately implemented, 
can reduce the IRB review burdens and the regulatory delays that slow scientific growth and 
lifesaving initiatives. I submit that their proposal for improvement can work, but only if the 
stakeholders are willing to work together to understand their policies on protection of human 
subjects and are flexible in changing policies and procedures that neither are useful in 
protecting those who volunteer for research nor serve, in a timely fashion, the needs of 
service members (Lo and Barnes 2011).
I agree with Freed and colleagues (2016) that such problems demand systemic and structural 
responses. They are correct in recommending that there be standardization of the IRB 
processes and forms across the DoD. There is concern that collaborative research involving 
minorities and underserved populations in multiple geographic regions often requires 
multiple IRB reviews, which stalls timely and effective conduct of such research. This led 
RTRN in 2009 to create and streamline the IRB review process to ensure compliance and 
enhance the quality of health disparities research by engaging community partners. Since 
institutional requirements and interpretation of ethical standards vary and make navigation 
cumbersome, the IRB harmonization initiative was directed at making the informed consent 
process and research protocol less complicated (Hammatt et al. 2011). If the uniformed 
services and the National Capital Region can develop and use an IRB Reliance Agreement 
Form, the administrative burden of submitting and reviewing forms that “contain similar 
information but are in different format” can be reduced (Freed et al. 2016). Still, all 
stakeholders must be involved in the design, development, and implementation of such a 
form.
To identify strategies addressing the complexity of multiple reviews across the RTRN 
consortium, the RTRN Ethics and Regulatory Subcommittee formed an IRB Harmonization 
Working Group in 2009. It was necessary to involve diverse stakeholders in the process, 
from conceptualization of the harmonization to its implementation. Thus, this group 
included community-based researchers, community faculty members, a physician, an 
attorney, and the IRB director. The Working Group members had expertise in IRB 
management, academic research, community engagement, clinical data services, and 
informatics. It was appropriate to seek and obtain institutional support from stakeholders at 
RCMI grantee institutions. The Working Group had meetings with institutional officials who 
had authority to review and sign agreements on behalf of the institution, those responsible 
for overseeing IRB activities, and other IRB administrators. Such meetings accelerated the 
pace of negotiations for the reliance agreement at each institution. As a strategy to promote 
interinstitutional IRB reliance, the RTRN Steering Committee approved use of a 
memorandum of understanding (MOU) among the 18 institutions. Meetings with individuals 
having decision-making authority within each institution were convened to understand the 
cultural context and discuss implementation of the MOU, how to monitor the IRB Reliance 
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Agreement after it is signed by the institutional official, and how to revise the Federal Wide 
Assurance to reflect each institution’s potential reliance upon IRB reviews by other 
institutions. The elements of the agreement have been reported elsewhere (Hammatt et al. 
2011). In sum, if properly applied to the military treatment context, these processes can 
engage the servicemen and -women, just as the diverse RTRN community was engaged, to 
identify what is important, mark the federally funded studies that are time sensitive, and 
prioritize them for action by the IRBs.
Freed and colleagues (2016) identified the need for transparency of the processes and the 
collection of metrics that can aid in understanding of the processes and in balancing the cost 
of doing research with the cost of reviewing research. I agree. Between 2009 and 2010, the 
RTRN Working Group on IRB Harmonization tested the foundation for a simplified IRB 
among its Small Grants Program grantee executing multisite projects. By 2014, a standard 
operating procedure and a reliance document form had been designed and were to be vetted 
by all parties concerned. An attempt at developing a standard informed consent that was 
examined by community partners for the RTRN consortium had been made, and plans were 
in place for data collection on RTRN-affiliated studies pre and post IRB harmonization to 
understand the impact of IRB harmonization on reducing administrative burden for 
investigators conducting joint project across the network (Hammatt et al. 2011). Education 
across the network was also relevant. In 2014, several IRB Café seminars were conducted 
for research investigators to showcase the resources available at each institution and to 
develop trust in the capacity of each IRB. By 2015, the Ethics and Regulatory Sub-
committee of the RTRN had completed and ratified with RTRN senior administration the 
necessary documents that can assist investigators in multi-institutional collaborative work to 
reduce the IRB review burdens and the regulatory delays. This model, which streamlines 
research efforts and preserves local sociocultural aspects of human study participant ethics 
and respect, can be used by the military and others dedicated to improving human health 
through basic, clinical, translational, and community-engaged research (Hammatt et al. 
2011).
Clearly, the systemic and structural challenges that the authors of this article have 
highlighted are serious enough to warrant attention, consideration, and resolution (Williams, 
Gatien, and Hagerty 2012). The authors assert that their “experience suggests that the actual 
IRB committees are not the main problem. Instead, the main problems are the bureaucracies 
flanking these committees” (Freed et al. 2016, 36). Perhaps the “bureaucracies” need to hear 
from those who would benefit from improvements to the system. Social justice demands that 
concerned people consider these observations and think “outside the box” to implement 
collaborative models sensitive to community beneficence for all research stakeholders. I 
conclude that in this venture there is no substitute for conversations that engage the IRB 
workforce and those who have regulatory and signatory authority as partners within the 
military. They must be encouraged to embrace the goals of science reviews within a 
reasonable time and to promote an effective and efficient system that enables service 
members to benefit from the care they need in order to fulfill their mission of protecting our 
country. For this task, the RTRN consortium has a template of experiences that can be 
usefully applied, as indicated in this commentary.
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